Inflammation: Planning for a Source of Pharmacokinetic/Pharmacodynamic Variability in Translational Studies

被引：22

作者：

Schmith, V. D. ^{[1
]}

Foss, J. F. ^{[2
]}

机构：

[1] GlaxoSmithKline, Dept Clin Pharmacol Modeling & Simulat, Res Triangle Pk, NC 27709 USA

[2] Cleveland Clin, Dept Gen Anesthesiol, Cleveland, OH 44106 USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2010年 / 87卷 / 04期

关键词：

DRUG-DISEASE INTERACTIONS; RHEUMATOID-ARTHRITIS; METABOLIZING-ENZYMES; PHARMACOKINETICS; TRANSPORTERS; PROPRANOLOL; PHARMACODYNAMICS; DISPOSITION; EXPRESSION; MEDIATORS;

D O I：

10.1038/clpt.2009.258

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The impact of inflammation on variability in the pharmacokinetics (PK) and pharmacodynamics (PD) of drugs should be considered in the design, analysis, and interpretation of clinical pharmacology studies. Data suggest that the metabolism and transport of drugs, as well as the expression of receptors, may change in the presence of inflammation. The clinical implications of these changes are not straightforward; they may vary depending on whether the inflammation is active or controlled and may change with time and successful treatment of the inflammation.

引用

页码：488 / 491

页数：4

共 50 条

[41] Translational pharmacokinetic/pharmacodynamic model for mRNA-0184, an investigational therapeutic for the treatment of heart failure [J].

Kaushal, Neeraj ;

Attarwala, Husain ;

Iqbal, Mir Javid ;

Saini, Rajnish ;

Van, Linh ;

Liang, Min .

CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (08)

[42] Drug-Drug Interaction Studies With Oral Contraceptives: Pharmacokinetic/Pharmacodynamic and Study Design Considerations [J].

Sun, Haiying ;

Sivasubramanian, Rama ;

Vaidya, Soniya ;

Barve, Avantika ;

Jarugula, Venkateswar .

JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 60 :S49-S62

[43] Meta-analysis of Pharmacokinetic/Pharmacodynamic Results of 3 Phase 1 Studies with Biosimilar Pegfilgrastim [J].

Gattu, Sreekanth ;

Wang, Jessie ;

Bellon, Anne ;

Schelcher, Celine ;

Nakov, Roumen ;

Arani, Ramin .

CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2021, 10 (10) :1130-1141

[44] A tissue cage model in calves for studies on pharmacokinetic/pharmacodynamic interactions of antimicrobials [J].

Greko, C ;

Finn, M ;

Öhagen, P ;

Franklin, A ;

Bengtsson, B .

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2003, 22 (04) :429-438

[45] Practical experience and issues in designing and performing population pharmacokinetic/pharmacodynamic studies [J].

Aarons, L ;

Balant, LP ;

Mentre, F ;

Rowland, M ;

Steimer, JL ;

Vozeh, S .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 49 (04) :251-254

[46] Saliva versus Plasma for Pharmacokinetic and Pharmacodynamic Studies of Fentanyl in Patients with Cancer [J].

Bista, Sudeep R. ;

Haywood, Alison ;

Norris, Ross ;

Good, Phillip ;

Tapuni, Angela ;

Lobb, Michael ;

Hardy, Janet .

CLINICAL THERAPEUTICS, 2015, 37 (11) :2468-2475

[47] Future in vitro and animal studies: Development of pharmacokinetic and pharmacodynamic efficacy predictors for tissue-based antibiotics [J].

Nightingale, CH .

PHARMACOTHERAPY, 2005, 25 (12) :146S-149S

[48] Pharmacokinetic and pharmacodynamic studies of nisoldipine-loaded solid lipid nanoparticles developed by central composite design [J].

Dudhipala, Narendar ;

Veerabrahma, Kishan .

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2015, 41 (12) :1968-1977

[49] Voclosporin Food Effect and Single Oral Ascending Dose Pharmacokinetic and Pharmacodynamic Studies in Healthy Human Subjects [J].

Mayo, Patrick R. ;

Huizinga, Robert B. ;

Ling, Spencer Y. ;

Freitag, Derrick G. ;

Aspeslet, Launa J. ;

Foster, Robert T. .

JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (08) :819-826

[50] Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection [J].

Venisse, Nicolas ;

Peytavin, Gilles ;

Bouchet, Stephane ;

Gagnieu, Marie-Claude ;

Garraffo, Rodolphe ;

Guilhaumou, Romain ;

Solas, Caroline .

ANTIVIRAL RESEARCH, 2020, 181

← 1 2 3 4 5 →